James A. Ankrum
Impact in
- Genetics top 0.2%
- Mesenchymal stem cell research
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications
Papers in
- Co-authors
- Jeffrey M. Karp (10 shared papers)Weian Zhao (3 shared papers)M. Monsur Ali (1 shared paper)Zhiqing Zhang (1 shared paper)Kaixiang Zhang (1 shared paper)Dong‐Ku Kang (1 shared paper)X. Chris Le (1 shared paper)Feng Li (1 shared paper)
- Journals
- Science Translational Medicine (5 papers)Scientific Reports (4 papers)Diabetes (4 papers)Toxicology (3 papers)Frontiers in Immunology (3 papers)
- Partner nations
- United StatesChinaIreland
In The Last Decade
James A. Ankrum
59 papers receiving 4.4k citations
James A. Ankrum's Hit Papers
Peers
Comparison fields: 5 of 141
- Genetics 2.0k
- Biomaterials 530
- Rehabilitation 205
- Molecular Biology 2.0k
- Surgery 1.2k
Countries citing papers authored by James A. Ankrum
This map shows the geographic impact of James A. Ankrum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Ankrum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Ankrum more than expected).
Fields of papers citing papers by James A. Ankrum
This network shows the impact of papers produced by James A. Ankrum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Ankrum. The network helps show where James A. Ankrum may publish in the future.
Co-authors
The 25 scholars most cited alongside James A. Ankrum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesenchymal stem cells: immune evasive, not immune privileged Hit paper breakdown → | 2014 | 1154 |
| 2 | Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine Hit paper breakdown → | 2014 | 888 |
| 3 | Mesenchymal stem cell therapy: Two steps forward, one step back Hit paper breakdown → | 2010 | 496 |
| 4 | Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines Hit paper breakdown → | 2019 | 295 |
| 5 | Manufacturing of primed mesenchymal stromal cells for therapy Hit paper breakdown → | 2019 | 267 |
| 6 | 2012 | 164 | |
| 7 | 2012 | 119 | |
| 8 | 2012 | 114 | |
| 9 | 2018 | 102 | |
| 10 | 2022 | 99 | |
| 11 | 2014 | 81 | |
| 12 | 2014 | 66 | |
| 13 | 2013 | 65 | |
| 14 | 2011 | 60 | |
| 15 | 2011 | 54 | |
| 16 | 2016 | 52 | |
| 17 | 2017 | 51 | |
| 18 | 2020 | 32 | |
| 19 | 2020 | 24 | |
| 20 | 2019 | 23 |
About James A. Ankrum
James A. Ankrum is a scholar working on Surgery, Genetics, Physiology, Molecular Biology and Epidemiology, having authored 67 papers that have together received 4.5k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (19 papers), Adipose Tissue and Metabolism (12 papers), Tissue Engineering and Regenerative Medicine (10 papers), Pancreatic function and diabetes (9 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers), Wound Healing and Treatments (6 papers), Lipid metabolism and biosynthesis (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Genetics (2.0k citations), Biomaterials (530 citations), Rehabilitation (205 citations), Molecular Biology (2.0k citations) and Surgery (1.2k citations). James A. Ankrum has collaborated with scholars based in United States, China and Ireland. Frequent co-authors include Jeffrey M. Karp, Weian Zhao, M. Monsur Ali, Zhiqing Zhang, Kaixiang Zhang, Dong‐Ku Kang, X. Chris Le, Feng Li, Jun Zhu and Guido Moll. Their work appears in journals such as Science Translational Medicine, Scientific Reports, Diabetes, Toxicology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.